Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dolutegravir Tenofovir'

Dolutegravir Tenofovir published presentations and documents on DocSlides.

New Antiretrovirals for the Treatment

New Antiretrovirals for the Treatment

  • alida-meadow
  • 0 Slides

of HIV. . Convenience, tolerability, simplicity....

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

  • quinn
  • 13 Slides

SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

  • roxanne
  • 9 Slides

FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...

Dolutegravir vs. Raltegravir

Dolutegravir vs. Raltegravir

  • zoe
  • 9 Slides

SPRING-2 Study. Dolutegravir. versus Raltegravir....

Dolutegravir ( Tivicay )

Dolutegravir ( Tivicay )

  • brown
  • 100 Slides

Prepared by:. Brian R. Wood, MD. David H. Spach, M...

Antiretroviral Updates:

Antiretroviral Updates:

  • tatyana-admore
  • 0 Slides

New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

  • yoshiko-marsland
  • 0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

The Bangkok Tenofovir Study

The Bangkok Tenofovir Study

  • marina-yarberry
  • 41 Slides

An HIV pre-exposure prophylaxis trial in Thailand...

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi

  • conchita-marotz
  • 0 Slides

A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

Switching the NRTI Backbone to Tenofovir DF-Emtricitabine

  • reese
  • 5 Slides

TOTEM. Switching the NRTI Backbone to Tenofovir DF...

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

  • kylie
  • 7 Slides

STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...

Simplification to Efavirenz-Tenofovir DF-Emtricitabine

Simplification to Efavirenz-Tenofovir DF-Emtricitabine

  • valerie
  • 7 Slides

ADONE Trial. Simplification to Efavirenz-Tenofovir...

2013 Asilomar HIV Medical Update

2013 Asilomar HIV Medical Update

  • luanne-stotts
  • 74 Slides

David Spach, MD. Clinical Director, Northwest AET...

New regimen for $75 a year

New regimen for $75 a year

  • tawny-fly
  • 0 Slides

New pricing agreement will speed up access to gen...

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

  • debby-jeon
  • 0 Slides

HIV Drug Resistance (HIVDR) and Antimicrobial Res...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

  • scarlett
  • 28 Slides

Judith S. Currier, MD, MSc. Professor of Medicine....

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

  • tripp
  • 15 Slides

Associate Dean for Global Health. University of Al...

HIV Medication Overview

HIV Medication Overview

  • kittie-lecroy
  • 63 Slides

John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. A...

State

State

  • pasty-toler
  • 49 Slides

of the evidence from oral and topical . PrEP. ef...

Tenofovir

Tenofovir

  • alida-meadow
  • 101 Slides

based . PrEP. technologies in women : . what do...

Major Changes to the HHS Adult and Adolescent HIV Treatment

Major Changes to the HHS Adult and Adolescent HIV Treatment

  • tawny-fly
  • 14 Slides

Brian R. Wood, MD. Assistant Professor of Medicin...

Conflict of Interest “No conflicts of interest to declare”

Conflict of Interest “No conflicts of interest to declare”

  • karlyn-bohler
  • 0 Slides

Lessons Learned from Tenofovir Vaginal Gel Studie...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • liane-varnes
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

ART Initiation: PrEP and

ART Initiation: PrEP and

  • alida-meadow
  • 0 Slides

Treatment-naïve Patients . Clinical Instructor, ...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • natalia-silvester
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Florida AIDS Drug Assistance

Florida AIDS Drug Assistance

  • yoshiko-marsland
  • 0 Slides

Program. Improving Health. . . Promoting Wellness...

Generic tenofovir disoproxil

Generic tenofovir disoproxil

  • SunkissedBabe
  • 1 Slides

fumarate and . emtricitabine. tablets obtained fr...

Switching from TDF/FTC to TAF/

Switching from TDF/FTC to TAF/

  • fanny
  • 6 Slides

FTC. Study 311-1089. Switching from TDF/FTC to TAF...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

  • micah
  • 16 Slides

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

  • cheryl-pisano
  • 0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

  • ellena-manuel
  • 0 Slides

Learning Objectives. EARLY VS DEFERRED ART. The C...

Essentials for Optimal Care of HIV Patients

Essentials for Optimal Care of HIV Patients

  • marina-yarberry
  • 0 Slides

Evidence-Based Approaches. Simply Speaking. ®. ...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

  • alida-meadow
  • 22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

  • neoiate
  • 15 Slides

*\n\b...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

  • megan
  • 44 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Copyright © 2024 DocSlides. All Rights Reserved